Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

Abstract

CONTEXT Drug intervention in placebo-controlled trials has been beneficial in isolated systolic hypertension. OBJECTIVE To test the hypothesis that losartan improves outcome better than atenolol in patients with isolated systolic hypertension and electrocardiographically documented left ventricular hypertrophy (ECG-LVH). DESIGN Double-blind, randomized… (More)

Topics

10 Figures and Tables

Slides referencing similar topics